Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Point-of-Care Molecular Diagnostics Revenue

1.5 Market Analysis by Type

1.5.1 Global Point-of-Care Molecular Diagnostics Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 PCR-based

1.5.3 Genetic Sequencing-based

1.5.4 Hybridization-based

1.5.5 Microarray-based

1.6 Market by Application

1.6.1 Global Point-of-Care Molecular Diagnostics Market Share by Application: 2022-2027

1.6.2 Infectious Diseases

1.6.3 Oncology

1.6.4 Hematology

1.6.5 Prenatal Testing

1.6.6 Endocrinology

1.6.7 Other

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Point-of-Care Molecular Diagnostics Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Point-of-Care Molecular Diagnostics Market Players Profiles

3.1 Danaher Corporation

3.1.1 Danaher Corporation Company Profile

3.1.2 Danaher Corporation Point-of-Care Molecular Diagnostics Product Specification

3.1.3 Danaher Corporation Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Johnson and Johnson

3.2.1 Johnson and Johnson Company Profile

3.2.2 Johnson and Johnson Point-of-Care Molecular Diagnostics Product Specification

3.2.3 Johnson and Johnson Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 BioMerieux

3.3.1 BioMerieux Company Profile

3.3.2 BioMerieux Point-of-Care Molecular Diagnostics Product Specification

3.3.3 BioMerieux Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 F. Hoffmann-La Roche AG

3.4.1 F. Hoffmann-La Roche AG Company Profile

3.4.2 F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Product Specification

3.4.3 F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Abbott Laboratories, Bayer Healthcare

3.5.1 Abbott Laboratories, Bayer Healthcare Company Profile

3.5.2 Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Product Specification

3.5.3 Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Becton, Dickinson and Company

3.6.1 Becton, Dickinson and Company Company Profile

3.6.2 Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Product Specification

3.6.3 Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Cepheid, Inc.

3.7.1 Cepheid, Inc. Company Profile

3.7.2 Cepheid, Inc. Point-of-Care Molecular Diagnostics Product Specification

3.7.3 Cepheid, Inc. Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Bio-Rad Laboratories, Inc.

3.8.1 Bio-Rad Laboratories, Inc. Company Profile

3.8.2 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Product Specification

3.8.3 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Point-of-Care Molecular Diagnostics Market Competition by Market Players

4.1 Global Point-of-Care Molecular Diagnostics Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Market Players (2016-2021)

4.3 Global Point-of-Care Molecular Diagnostics Average Price by Market Players (2016-2021)

5 Global Point-of-Care Molecular Diagnostics Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.1.2 Point-of-Care Molecular Diagnostics Key Players in North America (2016-2021)

5.1.3 North America Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.1.4 North America Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.2.2 Point-of-Care Molecular Diagnostics Key Players in East Asia (2016-2021)

5.2.3 East Asia Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.2.4 East Asia Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.3.2 Point-of-Care Molecular Diagnostics Key Players in Europe (2016-2021)

5.3.3 Europe Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.3.4 Europe Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.4.2 Point-of-Care Molecular Diagnostics Key Players in South Asia (2016-2021)

5.4.3 South Asia Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.4.4 South Asia Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.5.2 Point-of-Care Molecular Diagnostics Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.5.4 Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.6.2 Point-of-Care Molecular Diagnostics Key Players in Middle East (2016-2021)

5.6.3 Middle East Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.6.4 Middle East Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.7.2 Point-of-Care Molecular Diagnostics Key Players in Africa (2016-2021)

5.7.3 Africa Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.7.4 Africa Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.8.2 Point-of-Care Molecular Diagnostics Key Players in Oceania (2016-2021)

5.8.3 Oceania Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.8.4 Oceania Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.9.2 Point-of-Care Molecular Diagnostics Key Players in South America (2016-2021)

5.9.3 South America Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.9.4 South America Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Point-of-Care Molecular Diagnostics Market Size (2016-2021)

5.10.2 Point-of-Care Molecular Diagnostics Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021)

5.10.4 Rest of the World Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021)

6 Global Point-of-Care Molecular Diagnostics Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Point-of-Care Molecular Diagnostics Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Point-of-Care Molecular Diagnostics Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Point-of-Care Molecular Diagnostics Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Point-of-Care Molecular Diagnostics Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Point-of-Care Molecular Diagnostics Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Point-of-Care Molecular Diagnostics Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Point-of-Care Molecular Diagnostics Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Point-of-Care Molecular Diagnostics Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Point-of-Care Molecular Diagnostics Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Point-of-Care Molecular Diagnostics Consumption by Countries

7 Global Point-of-Care Molecular Diagnostics Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Point-of-Care Molecular Diagnostics (2022-2027)

7.2 Global Forecasted Revenue of Point-of-Care Molecular Diagnostics (2022-2027)

7.3 Global Forecasted Price of Point-of-Care Molecular Diagnostics (2022-2027)

7.4 Global Forecasted Production of Point-of-Care Molecular Diagnostics by Region (2022-2027)

7.4.1 North America Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.3 Europe Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.7 Africa Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.9 South America Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Point-of-Care Molecular Diagnostics Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Point-of-Care Molecular Diagnostics by Application (2022-2027)

8 Global Point-of-Care Molecular Diagnostics Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

8.2 East Asia Market Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

8.3 Europe Market Forecasted Consumption of Point-of-Care Molecular Diagnostics by Countriy

8.4 South Asia Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

8.5 Southeast Asia Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

8.6 Middle East Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

8.7 Africa Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

8.8 Oceania Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

8.9 South America Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

8.10 Rest of the world Forecasted Consumption of Point-of-Care Molecular Diagnostics by Country

9 Global Point-of-Care Molecular Diagnostics Sales by Type (2016-2027)

9.1 Global Point-of-Care Molecular Diagnostics Historic Market Size by Type (2016-2021)

9.2 Global Point-of-Care Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

10 Global Point-of-Care Molecular Diagnostics Consumption by Application (2016-2027)

10.1 Global Point-of-Care Molecular Diagnostics Historic Market Size by Application (2016-2021)

10.2 Global Point-of-Care Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

11 Global Point-of-Care Molecular Diagnostics Manufacturing Cost Analysis

11.1 Point-of-Care Molecular Diagnostics Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Point-of-Care Molecular Diagnostics

12 Global Point-of-Care Molecular Diagnostics Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Point-of-Care Molecular Diagnostics Distributors List

12.3 Point-of-Care Molecular Diagnostics Customers

12.4 Point-of-Care Molecular Diagnostics Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Point-of-Care Molecular Diagnostics Revenue (US$ Million) 2016-2021

Table 6. Global Point-of-Care Molecular Diagnostics Market Size by Type (US$ Million): 2022-2027

Table 7. PCR-based Features

Table 8. Genetic Sequencing-based Features

Table 9. Hybridization-based Features

Table 10. Microarray-based Features

Table 16. Global Point-of-Care Molecular Diagnostics Market Size by Application (US$ Million): 2022-2027

Table 17. Infectious Diseases Case Studies

Table 18. Oncology Case Studies

Table 19. Hematology Case Studies

Table 20. Prenatal Testing Case Studies

Table 21. Endocrinology Case Studies

Table 22. Other Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Point-of-Care Molecular Diagnostics Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Point-of-Care Molecular Diagnostics Market Growth Strategy

Table 46. Point-of-Care Molecular Diagnostics SWOT Analysis

Table 47. Danaher Corporation Point-of-Care Molecular Diagnostics Product Specification

Table 48. Danaher Corporation Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Johnson and Johnson Point-of-Care Molecular Diagnostics Product Specification

Table 50. Johnson and Johnson Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. BioMerieux Point-of-Care Molecular Diagnostics Product Specification

Table 52. BioMerieux Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Product Specification

Table 54. Table F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Product Specification

Table 56. Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Product Specification

Table 58. Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Cepheid, Inc. Point-of-Care Molecular Diagnostics Product Specification

Table 60. Cepheid, Inc. Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Product Specification

Table 62. Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Point-of-Care Molecular Diagnostics Production Capacity by Market Players

Table 148. Global Point-of-Care Molecular Diagnostics Production by Market Players (2016-2021)

Table 149. Global Point-of-Care Molecular Diagnostics Production Market Share by Market Players (2016-2021)

Table 150. Global Point-of-Care Molecular Diagnostics Revenue by Market Players (2016-2021)

Table 151. Global Point-of-Care Molecular Diagnostics Revenue Share by Market Players (2016-2021)

Table 152. Global Market Point-of-Care Molecular Diagnostics Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 155. North America Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 157. North America Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 159. East Asia Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 162. East Asia Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 164. East Asia Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 166. Europe Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 169. Europe Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 171. Europe Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 173. South Asia Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 176. South Asia Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 178. South Asia Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 180. Southeast Asia Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 183. Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 185. Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 187. Middle East Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 190. Middle East Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 192. Middle East Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 194. Africa Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 197. Africa Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 199. Africa Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 201. Oceania Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 204. Oceania Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 206. Oceania Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 208. South America Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 211. South America Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 213. South America Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 215. Rest of the World Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Point-of-Care Molecular Diagnostics Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Point-of-Care Molecular Diagnostics Market Share (2016-2021)

Table 218. Rest of the World Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Point-of-Care Molecular Diagnostics Market Share by Type (2016-2021)

Table 220. Rest of the World Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Point-of-Care Molecular Diagnostics Market Share by Application (2016-2021)

Table 222. North America Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 223. East Asia Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 224. Europe Point-of-Care Molecular Diagnostics Consumption by Region (2016-2021)

Table 225. South Asia Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 226. Southeast Asia Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 227. Middle East Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 228. Africa Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 229. Oceania Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 230. South America Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 231. Rest of the World Point-of-Care Molecular Diagnostics Consumption by Countries (2016-2021)

Table 232. Global Point-of-Care Molecular Diagnostics Production Forecast by Region (2022-2027)

Table 233. Global Point-of-Care Molecular Diagnostics Sales Volume Forecast by Type (2022-2027)

Table 234. Global Point-of-Care Molecular Diagnostics Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Point-of-Care Molecular Diagnostics Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Point-of-Care Molecular Diagnostics Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Point-of-Care Molecular Diagnostics Sales Price Forecast by Type (2022-2027)

Table 238. Global Point-of-Care Molecular Diagnostics Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Point-of-Care Molecular Diagnostics Consumption Value Forecast by Application (2022-2027)

Table 240. North America Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 241. East Asia Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 242. Europe Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 243. South Asia Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 245. Middle East Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 246. Africa Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 247. Oceania Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 248. South America Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027 by Country

Table 250. Global Point-of-Care Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Point-of-Care Molecular Diagnostics Revenue Market Share by Type (2016-2021)

Table 252. Global Point-of-Care Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Point-of-Care Molecular Diagnostics Revenue Market Share by Type (2022-2027)

Table 254. Global Point-of-Care Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2016-2021)

Table 256. Global Point-of-Care Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2022-2027)

Table 258. Point-of-Care Molecular Diagnostics Distributors List

Table 259. Point-of-Care Molecular Diagnostics Customers List





Figure 1. Product Figure

Figure 2. Global Point-of-Care Molecular Diagnostics Market Share by Type: 2021 VS 2027

Figure 3. Global Point-of-Care Molecular Diagnostics Market Share by Application: 2021 VS 2027

Figure 4. North America Point-of-Care Molecular Diagnostics Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 6. North America Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 7. United States Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 8. Canada Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 12. China Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 13. Japan Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 15. Europe Point-of-Care Molecular Diagnostics Consumption and Growth Rate

Figure 16. Europe Point-of-Care Molecular Diagnostics Consumption Market Share by Region in 2021

Figure 17. Germany Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 19. France Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 20. Italy Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 21. Russia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 22. Spain Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 25. Poland Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Point-of-Care Molecular Diagnostics Consumption and Growth Rate

Figure 27. South Asia Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 28. India Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Point-of-Care Molecular Diagnostics Consumption and Growth Rate

Figure 30. Southeast Asia Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 31. Indonesia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Point-of-Care Molecular Diagnostics Consumption and Growth Rate

Figure 37. Middle East Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 38. Turkey Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 40. Iran Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 42. Africa Point-of-Care Molecular Diagnostics Consumption and Growth Rate

Figure 43. Africa Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 44. Nigeria Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Point-of-Care Molecular Diagnostics Consumption and Growth Rate

Figure 47. Oceania Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 48. Australia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 49. South America Point-of-Care Molecular Diagnostics Consumption and Growth Rate

Figure 50. South America Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 51. Brazil Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Point-of-Care Molecular Diagnostics Consumption and Growth Rate

Figure 54. Rest of the World Point-of-Care Molecular Diagnostics Consumption Market Share by Countries in 2021

Figure 55. Global Point-of-Care Molecular Diagnostics Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Point-of-Care Molecular Diagnostics Price and Trend Forecast (2022-2027)

Figure 58. North America Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 59. North America Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 75. South America Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Point-of-Care Molecular Diagnostics Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Point-of-Care Molecular Diagnostics Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 79. East Asia Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 80. Europe Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 81. South Asia Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 82. Southeast Asia Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 83. Middle East Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 84. Africa Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 85. Oceania Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 86. South America Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 87. Rest of the world Point-of-Care Molecular Diagnostics Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Point-of-Care Molecular Diagnostics

Figure 89. Manufacturing Process Analysis of Point-of-Care Molecular Diagnostics

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Point-of-Care Molecular Diagnostics Supply Chain Analysis